Back to Search
MARIA WERNER-WASIK, M.D.
M.D.
Radiation Oncology Physician
NPI: 1467476713Individual
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
MD-049673-L(PA)
Research & Publications (20)
Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
PMID 17869017·Int J Radiat Oncol Biol Phys·2008
3-trial
Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration.
PMID 16015544·Semin Oncol·2005
8-other
Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk.
PMID 15005286·Hematol Oncol Clin North Am·2004
6-review
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.
PMID 11917282·Semin Radiat Oncol·2002
3-trial
Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.
PMID 14720361·Clin Lung Cancer·2001
8-other
Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
PMID 11516851·Int J Radiat Oncol Biol Phys·2001
8-other
Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
PMID 11121651·Int J Radiat Oncol Biol Phys·2000
8-other
Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.
PMID 11020565·Int J Radiat Oncol Biol Phys·2000
8-other
Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy.
PMID 19235368·Med Phys·2009
4-observational
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
PMID 19084346·Int J Radiat Oncol Biol Phys·2009
3-trial
Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts.
PMID 19042095·Int J Radiat Oncol Biol Phys·2009
4-observational
Cicatricial alopecia secondary to radiation therapy: case report and review of the literature.
PMID 18441767·Cutis·2008
5-case
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of nonacoustic cranial nerve schwannomas.
PMID 18981884·Neurosurgery·2008
8-other
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.
PMID 18922126·Future Oncol·2008
6-review
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.
PMID 18596429·Neurosurgery·2008
8-other
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
PMID 18501528·Int J Radiat Oncol Biol Phys·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 111 S 11TH ST
PHILADELPHIA, PA 19107 - Phone
- (215) 955-6702
Quick Facts
- NPI
- 1467476713
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile